Business
Amazon Workers Hold Walkout In Seattle Over Objections To Return-To-Work Policy
People watch from inside Amazon's Seattle headquarters as Amazon workers last year protested return to office requirements, among other issues. (David Ryder/Getty Images)

Amazon is going back to the office full-time. The rest of tech is not.

The “world’s largest startup” isn’t acting like one

In January, Amazon employees will have to go back to the office full time.

In order to “better set up to invent, collaborate, and be connected enough to each other and our culture to deliver the absolute best for customers and the business, we’ve decided that we’re going to return to being in the office the way we were before the onset of COVID,” CEO Andy Jassy said in a blog post Monday.

That puts the company, long known for its hard-driving and even abusive-seeming work culture, at odds with the rest of the tech industry.

In fact, rather than return to the office, tech companies have been getting more flexible in where people work, according to data from Flex Index, which surveys more than 9,000 firms on their office policies.

In 2024, the majority of tech firms (56%) let employees decide where they’d like to work. Another 23% are fully remote, while 18% are structured-hybrid, meaning employees are required to come in on some days. Only 3% of tech companies require their employees to be in the office full time, representing a decline from 2023.

When Amazon moved to three days in-office last year, the change was met with worker protests, and it’s likely we’ll see more this time. (It also will no doubt cause some workers to leave, which might just be another way for Amazon to cut costs.)

“In the immediate term, Amazon will see a lot of employee pushback and frustration. Employees that don't want to comply will immediately start looking for other opportunities,” Rob Sadow, CEO and co-founder of Flex Index, told Sherwood. “The job market in tech is tepid, but there are a lot of tech companies with more flexible postures who will jump at the opportunity to take talent from Amazon.”

He added, “All else being equal, the average employee will choose to go to a company that offers more flexibility. So Amazon may have to pay more vs. a competitor for the same talent, and will be confined in their hiring to people who live within a reasonable geographic radius of their offices.”

Other tech companies could decide to emulate Amazon, or scoop up the employees the new policies drive away.

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.